BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1105584)

  • 1. Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole.
    Daniels JC; Fajardo I; David JR
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4569-72. PubMed ID: 1105584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole.
    Daniels JC; Warren KS; David JR
    J Immunol; 1975 Nov; 115(5):1414-21. PubMed ID: 51891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of niridazole on mitogen induced lymphocyte proliferation.
    Moulton RG; Daniels JC
    Proc Soc Exp Biol Med; 1979 Mar; 160(3):378-81. PubMed ID: 372953
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-T cell activity of niridazole in experimental autoimmune encephalomyelitis.
    Bernard CC; Leydon J; Mackay IR
    Int Arch Allergy Appl Immunol; 1977; 53(6):555-9. PubMed ID: 324924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and purification of immunosuppressive activity in the urine of rats and a human patient treated with niridazole.
    Lucas SV; Daniels JC; Schubert RD; Simpson JM; Mahmoud AA; warren KS; David JR; Webster LT
    J Immunol; 1977 Feb; 118(2):418-22. PubMed ID: 320258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of niridazole as a suppressant of cellular immunity in chickens.
    Walser MM
    Am J Vet Res; 1978 Nov; 39(11):1858-60. PubMed ID: 736345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of suppressor cells in the production of macrophage migration inhibition factor.
    Fox RA; Rajaraman K
    Immunol Commun; 1978; 7(3):311-21. PubMed ID: 350758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-induced suppressor factor (HSF): effect on migration inhibitory factor (MIF) production and proliferation.
    Rocklin RE
    J Immunol; 1977 May; 118(5):1734-8. PubMed ID: 67146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of niridazole in cellular immunity in vivo and in vitro.
    Solbach W; Wagner H; Röllinghoff M
    Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea-pigs. IV. failure to inhibit mononuclear cell accumulation with niridazole.
    Rudofsky UH; Pollara B
    Clin Exp Immunol; 1977 Mar; 27(3):522-5. PubMed ID: 862238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niridazole-mediated modulation of suppressor cells in Wistar rats.
    Sainis KB; Gadgil MB; Phondke GP
    Immunopharmacology; 1984 Oct; 8(2):61-8. PubMed ID: 6239839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional activation of immune lymphocytes by antigenic stimulation in cell-mediated immunity. IV. Role of macrophage and its soluble factor in antigen-induced MIF production of immune T lymphocytes.
    Yamamoto Y; Onoue K
    J Immunol; 1979 Mar; 122(3):942-8. PubMed ID: 376710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen handling by guinea pig macrophages: further evidence for the sequestration of antigen relevant for activation of primed T lymphocytes.
    Ellner JJ; Lipsky PE; Rosenthal AS
    J Immunol; 1977 Jun; 118(6):2053-7. PubMed ID: 325135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial inhibition of cell-mediated immunity (CMI) by niridazole: effect upon development of autoimmune aspermatogenic orchitis (AIAO) in guinea pigs.
    Nemirovsky MS
    Am J Reprod Immunol (1980); 1982 Apr; 2(2):79-86. PubMed ID: 7102889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aflatoxin on the cellular immune system.
    Pier AC; Fichtner RE; Cysewski SJ
    Ann Nutr Aliment; 1977; 31(4-6):781-8. PubMed ID: 350119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole.
    Webster LT; Butterworth AE; Mahmoud AA; Mngola EN; Warren KS
    N Engl J Med; 1975 May; 292(22):1144-7. PubMed ID: 1124104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses.
    Pelley RP; Pelley RJ; Stavitsky AB; Mahmoud AA; Warren KS
    J Immunol; 1975 Dec; 115(6):1477-82. PubMed ID: 1184961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of contact sensitivity by IgG1 antihapten antibody. IgG1 antihapten antibody suppresses migration inhibitory factor production by lymph node cells.
    Katayama I; Nishioka K
    Int Arch Allergy Appl Immunol; 1983; 70(2):178-84. PubMed ID: 6337109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked suppression of cell-mediated immunity with niridazole: first report.
    Mahmoud AA; Warren KS; Mandel MA
    Surg Forum; 1974; 25(0):514-6. PubMed ID: 4612800
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of disodium cromoglycate on lymphocyte response to antigen and mitogen.
    Walker DM; Dolby AE
    Int Arch Allergy Appl Immunol; 1975; 49(3):303-9. PubMed ID: 807527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.